1. Home
  2. NWGL vs RANI Comparison

NWGL vs RANI Comparison

Compare NWGL & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • RANI
  • Stock Information
  • Founded
  • NWGL 2008
  • RANI 2012
  • Country
  • NWGL Macau
  • RANI United States
  • Employees
  • NWGL N/A
  • RANI N/A
  • Industry
  • NWGL
  • RANI Medicinal Chemicals and Botanical Products
  • Sector
  • NWGL
  • RANI Health Care
  • Exchange
  • NWGL Nasdaq
  • RANI Nasdaq
  • Market Cap
  • NWGL 22.8M
  • RANI 24.2M
  • IPO Year
  • NWGL 2023
  • RANI 2021
  • Fundamental
  • Price
  • NWGL $1.43
  • RANI $1.64
  • Analyst Decision
  • NWGL
  • RANI Strong Buy
  • Analyst Count
  • NWGL 0
  • RANI 4
  • Target Price
  • NWGL N/A
  • RANI $7.75
  • AVG Volume (30 Days)
  • NWGL 16.3K
  • RANI 24.5M
  • Earning Date
  • NWGL 11-29-2025
  • RANI 11-13-2025
  • Dividend Yield
  • NWGL N/A
  • RANI N/A
  • EPS Growth
  • NWGL N/A
  • RANI N/A
  • EPS
  • NWGL N/A
  • RANI N/A
  • Revenue
  • NWGL $21,539,347.00
  • RANI $1,200,000.00
  • Revenue This Year
  • NWGL N/A
  • RANI N/A
  • Revenue Next Year
  • NWGL N/A
  • RANI N/A
  • P/E Ratio
  • NWGL N/A
  • RANI N/A
  • Revenue Growth
  • NWGL N/A
  • RANI N/A
  • 52 Week Low
  • NWGL $0.91
  • RANI $0.39
  • 52 Week High
  • NWGL $6.61
  • RANI $2.81
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 47.91
  • RANI 92.92
  • Support Level
  • NWGL $1.43
  • RANI $0.46
  • Resistance Level
  • NWGL $1.57
  • RANI $0.50
  • Average True Range (ATR)
  • NWGL 0.09
  • RANI 0.11
  • MACD
  • NWGL -0.02
  • RANI 0.08
  • Stochastic Oscillator
  • NWGL 15.17
  • RANI 66.32

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: